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Background
Stress induced hyperglycaemia is prevalent in critical care. Tight glycaemic 
control can significantly improve clinical outcomes. Model-based and
 
 
model-derived methods, such as SPRINT in Christchurch, have shown 
significant mortality reductions. This research uses prediction validation 
on an improved metabolic control model for real-time glycaemic control. 
A stochastic insulin sensitivity variability model is derived to
 
capture
 
 
patient dynamics hour to hour. The BG distribution resulting from a given 
intervention can thus be derived, enabling better control and safety.
Results
Parameter identification:
The pG
 
and EGP values found agreed well with literature. Patient specific 
values resulted in no performance improvement. 
pG
 
= 0.006 min-1
EGP = 1.16 mmol.min-1
Model Validation:
Fitting and prediction errors (median, IQR, 90% CI) are:
All errors are well within the measurement error of 7-12%. Predictions 
outside measurement error are primarily due to outlying measurement 
errors or sensor failures.
Conclusions
Model-based tight glycaemic control is primarily a function of model 
quality. A new, more physiologically relevant control model is
 
 
presented and validated over a 270 patient data set. Prediction and 
fitting errors lie within measurement error, indicating a suitability 
for clinical use.
A stochastic model is developed and shows the same trends expected 
in the dynamic, critically ill patient who gets well slowly, can
 
decline 
quite rapidly in some (more rare) cases.
The combination of these models is suitable for use in acute and
 
critical care settings
This deterministic + stochastic model combination has already been 
applied successfully in 24-hour NICU trials.
Models &
 
Methods
Data: N = 270 patients (≥
 
24 hour stay) and 47,126 hours
 
from patients on 
SPRINT at Christchurch Hospital
Population Parameters:
Time-Varying Parameters: Insulin Sensitivity (SI
 
)
Cohort-Specific Parameters: EGP and pG
 
identified using a grid search 
based on minimal prediction and fitting errors, while held constant over 
the entire
 
cohort.
ID Method: An Integral-based method is used to identify time-varying 
insulin sensitivity for virtual patient trials. 
Virtual Patients: are created by identifying time-varying SI
 
(t) profiles for 
each patient to be used with different interventions. Prediction
 
errors 
are the error using the known intervention.
Stochastic Model: The 44,386 hourly SI
 
(t) values are used to evaluate the 
hour to hour change ΔSI
 
(t). A 2D kernel density estimation method is 
used to construct the model. Given a current identified SI
 
(t) value, the 
glucose levels can be calculated over the next hour for a given 
intervention.
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= 0.0154 l.mU-1 αI
 
= 0.0017 l.mU-1
VG
 
= 13.3 l VI
 
= 3.15 l
k = 0.0198 min-1 n = 0.16 min-1
d1
 
= 0.0347 min-1 d2
 
= 0.0069 min-1
0 5 7 12 25 50
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Absolute error (%)
C
um
ul
at
iv
e 
pr
ob
ab
lilt
y
CDFs for 1hr ahead prediction error by-patient (270 Patients with stay >= 24hrs)
 
 
New Model Prediction (constant S
I
)
New Model Prediction (stochastic S
I
)
Old Model Prediction
New Model Fitting
Old Model Fitting
0 5 7 12 25 50
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Absolute error (%)
C
um
ul
at
iv
e 
pr
ob
ab
lilt
y
CDFs for 1hr ahead prediction error by-patient (270 Patients with stay >= 24hrs)
 
 
Old Model Median Patient
New Model (const S
I
) Median Patient
New Model (stochastic S
I
) Median Patient
0 5 7 12 25 50
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Absolute error (%)
C
um
ul
at
iv
e 
pr
ob
ab
lilt
y
CDFs for fitting error by-patient (270 Patients with stay >= 24hrs)
 
 
Old Model Median Patient
New Model Median Patient
pG
EG
P
Median Absolute Fitting Error By-Cohort (%)
 
 
0 0.006 0.01 0.015 0.02 0.025 0.03 0.035 0.04 0.045 0.05
0
0.5
1.16
1.5
2
2.5
3
3.5
1
1.2
1.4
1.6
1.8
2
2.2
2.4
2.6
2.8
3
pG
EG
P
Median Absolute Prediction Error By-Cohort (%)
 
 
0 0.006 0.01 0.015 0.02 0.025 0.03 0.035 0.04 0.045 0.05
0
0.5
1.16
1.5
2
2.5
3
3.5
5
5.5
6
6.5
7
7.5
8
Figure 3. Hourly variation in SI with fitted stochastic model.
Figure 1. Fitted and actual BG with modelled SI
Figure 4. Prediction and fitting error results comparison
Figure 5. Error surfaces used for parameter identification
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Figure 2. Compartmental Glucose-Insulin model
